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ABSTRACT
T-cell intracellular antigen (TIA)-proteins are known
regulators of alternative pre-mRNA splicing. In
this study, pull-down experiments and mass
spectrometry indicate that TIAR/TIAL1 and hnRNP
C1/C2 are associated in HeLa nuclear extracts.
Co-immunoprecipitation and GST-pull-down
assays confirmed this interaction. Interestingly,
binding requires the glutamine-rich (Q-rich)
C-terminal domain of TIAR and the leucine-rich
plus acidic residues-rich C-terminal domains of
hnRNP C1/C2. This interaction also occurs in an
RNA-dependent manner. Recombinant GFP-TIAR
and RFP-hnRNP C1 proteins display partial nuclear
co-localization when overexpressed in HeLa cells,
and this requires the Q-rich domain of TIAR.
hnRNP C1 overexpression in the presence of
rate-limiting amounts of TIAR in HeLa and HEK293
cells affects alternative splicing of Fas and FGFR2
minigenes, promoting Fas exon 6 and FGFR2 exon
K-SAM skipping, respectively. The repressor activity
of hnRNP C1 on Fas exon 6 splicing is mediated by
Hu antigen R (HuR). Experiments involving tethering
approaches showed that the repressor capacity of
hnRNP C1 is associated with an exonic splicing
silencer in Fas exon 6. This effect was reversed by
splice-site strengthening and is linked to its basic
leucine zipper-like motif. These results suggest
that hnRNP C1/C2 acts as a bridge between HuR
and TIAR to modulate alternative Fas splicing.
INTRODUCTION
Alternative pre-mRNA splicing is a major regulatory
process for generating transcriptome and proteome diver-
sity, with >95% of human multi-exon genes expressed
from alternatively spliced mRNAs (1,2). Alternative
splicing makes a signiﬁcant contribution to the temporal
and spatial diversity of protein isoforms in higher eukary-
otes (3). The alternatively spliced regions of these isoforms
include functional domains affecting features such as
binding to DNA, RNA or other proteins, intracellular
localization, enzymatic activity, regulation and stability
(3). Thus, this phenomenon effectively expands the
coding capacity of the human genome.
The vast majority of human introns do not contain bona
ﬁde consensus sequences at their splice sites, branch point
or polypyrimidine tract, and instead have weak splicing
signals with non-consensus features (4). Additional
sequence elements located in exons or introns are
involved in the differential use of splice sites. They are
divided into four categories according to their position
and function: exonic splicing enhancers (ESEs), exonic
splicing silencers (ESSs), intronic splicing enhancers
(ISEs) and intronic splicing silencers (ISSs). These
elements are often needed to identify authentic splicing
signals within long-non-coding introns and, thus, to
achieve correct splicing of exons. The ﬁne balance
between positive and negative regulation of splice site se-
lection is likely to involve the combinatorial and
coordinated action of cis-acting RNA sequence elements
and trans-acting protein regulators. These intricate
protein–RNA networks can be modulated in response to
physiological and pathological conditions (5).
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are a family of RNA-binding proteins that participate
in both constitutive and alternative pre-mRNA splicing
in mammalian cells (6). They are among the most
abundant RNA-binding proteins, forming the core of
the ribonucleoprotein complex that associates with
nascent transcripts in eukaryotic cells, packaging them
into hnRNP particles. The family has several members
and some of them are subject to alternative transcript
splicing and post-translational modiﬁcations. This struc-
tural variation is paralleled by wide functional diversity,
largely involving interactions with DNA or, more
commonly, RNA. They also recruit regulatory proteins
associated with DNA and RNA metabolism, and appear
to accompany transcripts throughout the life of the
mRNA (5,6).
T-cell intracellular antigen (TIA) proteins are involved
in controlling the metabolism and dynamics of both
nuclear and cytoplasmic transcriptomes through mechan-
isms involving transcription, alternative pre-mRNA
splicing and regulation of mRNA stability and translation
(7). TIA-1 and TIAR/TIAL1 (‘TIA-1 related/like protein’)
are structurally close to hnRNPs and composed of three
RNA recognition motifs (RRMs) and a glutamine-rich
(Q-rich) C-terminal domain (8,9). TIA proteins regulate
the alternative pre-mRNA splicing of  15% of alternative
cassette human exons as well as 50-splice-site selection of
Alu exons through binding to U-rich intronic stretches,
facilitating atypical 50-splice site recognition by U1 small
nuclear ribonucleoprotein (10–15). In addition, these
proteins regulate turnover and translation of cytoplasmic
mRNAs (7,16–19).
This work addresses the molecular mechanisms
underlying the regulation of Fas exon 6 splicing, an alter-
native splicing event that leads to the production of
mRNA encoding either a membrane-bound form of the
Fas receptor that promotes programmed cell death or a
soluble form that inhibits apoptosis. The process is
regulated in a number of physiological situations,
including activation-mediated T-cell death, and failure to
undergo the switch between isoforms is responsible
for certain autoimmune lymphoproliferative disorders
(13 and references therein). To improve our understanding
of the mechanisms and networks governing splice-site se-
lection, this study set out to identify nuclear proteins that
interact with TIA-proteins and determine the contribution
of these auxiliary proteins to the regulation of alternative
splicing. The author reports that the hnRNP C1/C2
protein inhibits splicing through a mechanism involving
HuR and propose a model in which hnRNPC1/C2 and
TIAR play opposite roles in the regulation of alternative
pre-mRNA splicing.
MATERIALS AND METHODS
Cell cultures and plasmid constructs
HeLa and HEK293 cells were cultured under standard
conditions (20). Plasmids containing human hnRNP C1,
TIAR, TIARQ (lacking the Q-rich C-terminal domain)
cDNAs were generated by PCR using Pfu Turbo DNA
polymerase (Stratagene, USA). The wt, mutant U-20C,
and m0 Fas minigenes, and also the wt Fas 2xMS2
minigene and its derivatives were generated as described
earlier (11,21,22). The FGFR2 minigenes RK97 and
A7 were kindly provided by R. Breathnach (10,23).
HeLa nuclear extracts, preparation of recombinant
proteins and in vitro transcription and translation assays
HeLa nuclear extracts (NEs) were purchased from 4C
Biotech (Seneffe, Belgium). GST, MBP, GST-hnRNP
C1, GST-TIAR, MBP-HuR, and their mutant derivatives
were expressed in and puriﬁed as described earlier (22).
In vitro transcription and translation assays were per-
formed with a coupled transcription and translation
system (Promega, USA) (24). HeLa NEs were incubated
with calf intestinal alkaline phosphatase (calf intestinal
phosphatase, CIP; Roche, USA) according to the manu-
facturer’s instructions.
In-gel digestion of proteins and sample preparation
for mass spectrometric analysis
Protein spots were excised manually and then digested
automatically using a Proteineer DP protein digestion
station (Bruker-Daltonics, Bremen, Germany). The
digestion protocol used was that of Schevchenko et al.
(25), with minor variations (extended version in
Supplementary Data).
MALDI peptide mass ﬁngerprinting, LIFT TOF/
TOF acquisition and database searching
Peptide mass ﬁngerprint spectra were measured on a
Bruker Ultraﬂex TOF/TOF MALDI mass spectrometer
(Bruker-Daltonics, USA) (26) in positive ion reﬂector
mode (extended version in supplementary material).
Immunoprecipitation
Anti-TIA1, anti-TIAR and anti-hnRNP C1/C2 (Santa
Cruz Biotechnology, USA) and anti-U2AF65 (MC3
clone provided kindly by J. Valca ´ rcel), antibodies were
added to 10ml of NE in the absence of RNase A comple-
mented with buffer D to a total volume of 25ml and
incubated for 1h on ice. After addition of 20mlo f
protein G-Sepharose beads (1/1) and 40ml of IPP 100
buffer (10mM Tris pH 8.0, 100mM NaCl, 0.1%
NP-40), the reaction was incubated for 1h on a rotating
wheel at 4 C. A 10ml aliquot of each sample was removed
as loading control, and the beads were collected at
1000rpm and washed four times with ice-cold IPP 100
buffer. The loading control and pellet were analysed by
western blotting.
GST/MBP-pull-down and western blot analyses
A 1–2mg of recombinant GST, MBP, GST-TIAR,
GST-hnRNP C1, MBP-HuR, or their mutant derivatives
was incubated with either 5ml of NE, 1mg of puriﬁed
recombinant protein, 3mlo fin vitro translated hnRNP
C1, or partial fragments in rabbit reticulocyte lysates
(RRL, Promega, USA) in a total volume of 25ml, comple-
mented with buffer D (20mM HEPES pH 8.0, 20%
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After addition of 60ml of IPP 100 and 10ml of glutathione-
Sepharose 4B beads (GE Healthcare BioScience, UK)
pre-equilibrated in the same buffer, the reaction was
incubated for 1h on a rotating wheel at 4 C. A 10ml
aliquot of the reaction was removed as a loading control
and the pellet was washed four times with 400mlo f
ice-cold IPP 100 buffer. After sedimentation by centrifu-
gation at 1000rpm for 1min, the pellet was resuspended
in SDS loading buffer, fractionated together with an
aliquot of supernatant by electrophoresis on a 10% or
4–12% SDS-polyacrylamide gel (Invitrogen, USA). The
following antibodies were used: anti- hnRNP C1/C2 and
anti-TIAR (Santa Cruz Biotechnology, USA), anti-Stat3
(Phospho-Stat3 [Tyr705] [D3A7] XP
TM) rabbit mAb (Cell
Signalling, USA), Stat3 (C-20) rabbit polyclonal antibody
(sc-482) (Santa Cruz Biotechnology, USA), anti-MS2 coat
protein (kindly provided by Peter G. Stockley), anti-GFP
(JL-8, Clontech, USA), and anti-a-tubulin (B512, Sigma-
Aldrich, USA).
Fluorescence microscopy
After transfection (24h), the cells were analysed by
ﬂuorescence confocal microscopy with GFP and RFP ex-
citation ﬁlters. Fixation, permeabilization, To-pro-3
staining and visualization were performed as described
earlier (22).
Transfections
Exponentially grown HeLa and HEK293 cells were
transfected with 0.2–2.0mg of plasmid DNA as described
previously (10,11). Depletion of hnRNP C1/C2 gene ex-
pression was performed by pSUPER RNAi System
(Oligoengine, USA) using two independent speciﬁc
shRNAs against the 30-untranslated region of the
hnRNP C1/C2 mRNA as reported (27,28).
RNA puriﬁcation and analysis
Cytoplasmic RNA was isolated by using an RNeasy kit
(Qiagen, USA) and was analysed by RT–PCR and elec-
trophoresis. Control experiments with different input
amounts of RNA and different ratios between the alter-
natively spliced mRNAs indicated that the ampliﬁcation
of the species was quantitative under these conditions
(13,20).
RNA–protein interaction assays
Band shift and UV-mediated cross-linking assays were
performed as described earlier (13,22).
RESULTS
Polypeptides associated with TIAR in HeLa NEs
GST-pull down assays with recombinant GST alone and
GST-TIAR proteins were used to identify major nuclear
proteins interacting with TIAR from HeLa NEs.
Precipitates were separated on SDS–polyacrylamide gels
and stained with silver nitrate. Bands with increased in-
tensity compared with GST and GST-TIAR controls in
the absence of NEs (Figure 1A, compare lanes 2 and
3 with 4 and 5) were analysed by matrix-assisted laser
desorption ionization time-of-ﬂight mass spectroscopy
(MALDI-TOF-MS). Four polypeptides of around 125
(weakly stained), 52, 45 and 37kDa met the criteria
(Figure 1A and Supplementary Table IS). These proteins
were identiﬁed as matrin 3, an unnamed protein,
beta-actin and hnRNP C1/C2 (Figure 1B). The protein
score in MALDI-TOF-MS, accession number in
NCBInr, and role of these proteins in the nucleus are
summarised in Figure 1B. No other proteins were found
to be co-precipitated with TIAR following GST-pull
down. This may have been due to insufﬁcient amounts
of starting material or a failure to discriminate proteins
with similar molecular sizes by SDS–PAGE.
Co-immunoprecipitation and GST pull-down of hnRNP
C1/C2 and TIAR
To validate the association of hnRNP C1/C2 with TIAR,
hnRNP C1/C2 was immunoprecipitated from HeLa NEs
in the absence of RNase A treatment using speciﬁc
antibodies against TIA1, TIAR and hnRNP C1/C2, and
the presence of these proteins in the precipitates was
analysed by western blot (Figure 1C). As a control, the
presence of the splicing factor U2 snRNP auxiliary factor
65kDa (U2AF65) was also tested. One-tenth of the HeLa
NE prior to immunoprecipitation was also included as a
control for detection of all immunoprecipitated proteins
(Figure 1C, lane 1). Signiﬁcant levels of hnRNP C1/C2
and TIA proteins were detected reproducibly in corres-
ponding precipitates, but not in precipitates using beads
or anti-U2AF65 antibody (Figure 1C, compare lane 2 and
6 with 3–5). To conﬁrm the results obtained in
co-immunoprecipitation experiments, GST-pull-down
assays were also used. GST alone or a GST fusion con-
taining full-length TIAR were added to NEs and their
association with hnRNP C1/C2 analysed by western
blotting. hnRNP C1/C2 was pulled down by GST-TIAR
but not by GST alone (Figure 1D, compare lanes 2 and 3
with 4 and 5). Reciprocal experiments were also consistent
with a speciﬁc association between hnRNP C1 and TIAR.
Western blot analysis showed that TIAR was present in
GST-hnRNP C1 precipitates, whereas TIAR was not
precipitated by GST alone (Figure 1E, compare lanes 2
and 3 with 4 and 5). In all GST pull-down experiments,
aliquots of the HeLa NEs (25%) and supernatants (10%)
prior to precipitation were analysed in parallel. These
results conﬁrm the speciﬁcity of the association between
TIAR and hnRNP C1/C2 in HeLa NEs and suggest that
only a small portion of the total TIAR or hnRNP C1/C2
is involved in this interaction.
The Q-rich region of TIAR and the bZLP motif
of hnRNP C1/C2 are necessary for TIAR-hnRNP
association
Next, experiments were performed to identify the domain
within TIAR responsible for the interaction with hnRNP
C1/C2. TIAR contains three RRMs and a Q-rich
C-terminal domain (Figure 2A) (8,9). The Q-rich
domains of TIA proteins are reported to be essential for
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deletion mutant lacking the Q-rich domain (TIARQ)
was therefore generated. Recombinant GST fusions of
wt TIAR and TIARQ were expressed in Echerichia
coli and veriﬁed by immunoblot (Figure 2B). In GST
pull-down assays, only GST-TIAR was able to precipitate
signiﬁcant amounts of hnRNP C1/C2 when added to NEs.
To test whether TIAR contacts hnRNP C1 directly,
35S-labeled hnRNP C1 was generated by in vitro transla-
tion in RRL (Figure 2D, lanes 1 and 2), incubated with
GST-TIAR and GST-TIARQ and, after precipitation
using glutathione–agarose beads, the presence of hnRNP
C1 in the precipitates was assessed by fractionation in
denaturing SDS gels and autoradiography. hnRNP C1
co-precipitated strongly with GST-TIAR (Figure 2D,
compare lanes 3 and 4 with 5 and 6) but only marginally
with GST-TIARQ (Figure 2D, lanes 7 and 8). Similar
results were obtained in the presence and absence of
RNase A treatment (Figure 2E). RNase A activity was
veriﬁed by analysing degradation of the RRL RNA
present in the extract (Figure 2E, lower panel).
However, when the TIAR-hnRNP C1/C2 interaction
was analysed using HeLa NEs, the TIAR-hnRNP C1/C2
association appeared to be dependent upon RNA inter-
mediates (Figure 2F). These results suggest that there
is a protein–protein interaction mediated by the Q-rich
domain of TIAR and also an RNA-mediated interaction
between TIAR and hnRNP C1/C2. In addition, pull-down
hnRNP C1 by GST-TIAR from RRL does not necessarily
mean that the interaction is direct. It could be via other
proteins present in the RRL.
HnRNP C1/C2 is present in HeLa NEs as a phospho-
protein (30). To test whether the phosphorylation status
of hnRNP C1/C2 is implicated in the binding activity
mediated by TIAR, HeLa NEs were in vitro dephos-
phorylated with CIP. In GST pull-down assays,
GST-TIAR was unable to precipitate signiﬁcant
amounts of hnRNP C1/C2 when added to CIP-treated
NEs (Figure 2G). Protein dephosphorylation was
veriﬁed by western blotting to determine the relative
Figure 1. hnRNP C1/C2 is associated with TIAR in HeLa NEs. (A) Identiﬁcation of TIAR precipitates from GST pull-downs. HeLa NEs were
subjected to GST pull-down using either GST alone or GST-TIAR (GST-R). An aliquot (1ml) of NE and pulled down proteins were separated on
SDS-polyacrylamide gels and visualized by silver nitrate staining. The positions of recombinant GST-TIAR and GST proteins as well as the four
putative protein products and their apparent molecular sizes are indicated. Protein molecular weight markers are shown to the left. (B)
TIAR-interacting proteins identiﬁed by MALDI-TOF-MS. The protein products indicated in (A) were removed and identiﬁed by mass spectrometry.
The identities of the corresponding protein products are indicated. Four proteins were identiﬁed: matrin 3 (125kDa, weakly stained), an unnamed
protein (52kDa), beta-actin (45kDa) and hnRNP C1/C2 (37kDa). Their apparent molecular weights on SDS–PAGE are indicated. The protein score
in MALDI-TOF-MS, accession number in NCBInr, and role in the nucleus are also summarised. (C–E) Validation of the association between
hnRNP C1/C2 and TIAR. (C) Co-immunoprecipitation of hnRNP C1/C2 and TIA-proteins. HeLa NEs in the absence of RNase were processed for
immunoprecipitation using either beads alone or antibodies indicated and analysed by immunoblotting using the same speciﬁc antibodies. An aliquot
(10%) of HeLa NE prior to immunoprecipitation served as a control for the detection of protein immunoprecipitates. (D) Precipitation of hnRNP
C1/C2 by GST-TIAR. GST pull-down assays were carried out after addition of GST alone or GST-TIAR to NEs. (E) Precipitation of TIAR by
GST-hnRNP C1. GST pull-down assays were carried out after addition of GST alone or GST-hnRNP C1 to NEs. In both GST pull-down analyses
(D and E), aliquots of the HeLa NEs (25%) prior to pull-down assays, the corresponding supernatants (SN) (10%) and pulled down proteins were
analysed by western blotting in parallel using antibodies indicated. The positions of hnRNP C1/C2, TIAR and molecular weight markers are
indicated.
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and total transcription factor Stat3 in untreated ( ) HeLa
NEs and extracts treated with CIP (+) (Figure 2G,
lower panel). This result suggests that phosphorylation-
dephosphorylation cycles can regulate the degree of asso-
ciation between hnRNP C1/C2 and TIAR.
The protein sequence of hnRNP C1/C2, which is highly
conserved among vertebrates, contains an RNA-binding
domain (RBD), a basic leucine zipper (bZIP)-like motif
(bZLP), both involved in RNA binding, and an acidic
(Asp-Glu-rich) C-terminal domain (Figure 3A) (31–33).
To deﬁne the fragment of hnRNP C1 that interacts with
Figure 2. The Q-rich C-terminal domain of TIAR interacts with hnRNP C1/C2. (A) Schematic structure of human TIAR protein. The protein
sequence of TIAR contains three RRM 1–3 and a Q-rich C-terminal domain. RRMs are represented by boxes and the Q-rich domain by an oval.
The positions of speciﬁc residues limiting each domain are indicated. (B) Western-blot analysis of recombinant GST-TIAR wt and mutant versions.
Equal amounts (50ng) of GST-TIAR and GST-TIARQ (deletion mutant of TIAR without the Q-rich domain) were analysed by immunoblotting.
(C) The Q-rich domain of TIAR is required for precipitation of hnRNP C1/C2 by TIAR. GST pull-down assays were carried out after addition of
GST alone, GST-TIAR or GST-TIARQ to NEs, and the pellets were analysed by western blotting for the presence of hnRNP C1/C2. Aliquots of
the HeLa NEs (25%) prior to pull-down assays and the corresponding supernatants (SN) (10%) were also analysed in parallel. (D) Interaction
between GST-TIAR, GST-TIARQ, and in vitro translated hnRNP C1. Pull-down assays were carried out as in (C), using
35S-labeled hnRNP C1
translated in vitro. Pelleted proteins (P) and the pulled-down supernatant (SN) were analysed by SDS–PAGE and autoradiography. (E) Interaction
between TIAR and in vitro translated hnRNP C1 is RNA-independent in RRL. Assays were carried out as in (D), using
35S-labeled hnRNP
C1 translated in vitro in the presence (+) or absence ( ) of RNase A (10mg of RNase A for 15min at 37 C). The lower panel shows veriﬁcation of
the RNase A treatment by agarose gel electrophoresis and ethidium bromide staining of the remaining RNA in the binding reaction. The positions
of
35S-labeled hnRNP C1, endogenous RNA in RRL, and molecular weight markers are indicated. (F) RNA-dependent interaction between hnRNP
C1/C2 and TIAR in HeLa NEs. GST pull-down assays were carried out after addition of GST alone or GST-TIAR to NEs without ( ) or with (+)
RNase A treatment prior to the pull-down assays, as indicated in (E). The presence of hnRNP C1/C2 in the corresponding supernatants (SN)
and pellets (P) was analysed as in (C). In each case, the positions of hnRNP C1/C2 and molecular weight markers are indicated.
(G) Phosphorylation-dependent association between hnRNP C1/C2 and TIAR in HeLa NEs. GST pull-down assays were performed with HeLa
NEs incubated with (+) or without ( ) calf intestinal phosphatase (CIP) for 1h at 37 C. The presence of hnRNP C1/C2 in the corresponding
supernatants (SN) and pellets (P) was analysed as before. The lower panel shows veriﬁcation of the CIP treatment by western-blot analysis of relative
protein expression levels of phosphorylated (Tyr705) and total transcription factor Stat3. The positions of hnRNP C1/C2, phosphorylated, and total
Stat3 and molecular weight markers are indicated.
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taining functional domains of hnRNP C1 (Figure 3A)
were tested in pull-down assays using GST-TIAR or
GST-TIARQ. The results suggest that the hnRNP C1
fragments containing the bZLM and/or Asp/Glu-rich
C-terminal domains are more important than the
N-terminal residues in the interaction with TIAR
(Figure 3B). Interestingly, these results were conﬁrmed
when GST-TIARQ was used to test the binding to the
same fragments of hnRNP C1. As shown in Figure 3B,
GST-TIARQ was marginally co-precipitated with
separated fragments of 1–240 and 119–240 (Figure 3B,
compare lanes 1–5 with 6 and 7). These results suggest
that the contact surface between TIAR and hnRNP C1
mainly comprises the Q-rich domain of TIAR and the
bZLM motif of hnRNP C1.
TIAR and hnRNP C1 co-localize partially in the
nucleus of HeLa cells
HnRNP C1/C2 mostly accumulates in the nuclear com-
partment of HeLa cells (34), whereas TIAR shows a dual
nuclear-cytoplasmic localization pattern (22). To test the
TIAR-hnRNP C1 association and the participation of the
Q-rich domain of TIAR, their subcellular distribution was
compared by confocal microscopy. Expression constructs
containing TIAR and hnRNP C1 fused with GFP and
RFP, respectively, were transfected into HeLa cells and
the subcellular localization of the fusion proteins
analysed (Figure 4). HnRNP C1 was only observed in
the cell nucleus, whereas TIAR was detected in both the
nucleus and cytoplasm (Figure 4A, details in lower
panels). Interestingly, TIAR and hnRNP C1 had a
broad distribution in the nucleus and were present in a
diffuse pattern in the surrounding nucleoplasm. The
proteins appeared to be excluded from the nucleoli.
Merging the ﬂuorescence signals from GFP-TIAR and
RFP-hnRNP C1 indicated that TIAR and hnRNP C1
can co-localize in the nucleus (Figure 4A, detail in
Merge). To verify the role played by the Q-rich domain
of TIAR, GFP-TIARQ and RFP-hnRNP C1 were
co-expressed (Figure 4B). GFP-TIARQ displayed a
similar nuclear-cytoplasmic distribution to GFP-TIAR,
but there was only a partial overlap with RFP-
hnRNP C1 (Figure 4B, detail in Merge, and Figure 4C).
These results are consistent with our ﬁndings in
co-immunoprecipitation and GST pull-down analyses,
suggesting the capacity of TIAR to interact with hnRNP
C1 through its Q-rich domain.
Functional relevance of the TIAR-hnRNP C1 interaction
in the control of alternative splicing
To assess the functional signiﬁcance of the TIAR-hnRNP
C1 interaction in the control of alternative pre-mRNA
splicing, two TIAR-dependent splicing events were
investigated using human Fas apoptosis-promoting
receptor (Fas) and ﬁbroblast growth factor receptor-2
(FGFR2) minigenes. The Fas minigene contains human
Fas exons 5, 6 and 7 and introns 5 and 6 (11 and
Supplementary Figure 1SA). The 30-splice sites of intron
5 is weak and highly U2AF dependent, whereas the intron
63 0-splice site is strong and less U2AF dependent.
Experiments were performed to assess the response of
these introns to the presence of both proteins. The wt/
mutant Fas minigenes [U-20C, Fas minigene harboring a
mutation at the polypyrimidine tract of intron 5 that in-
creases exon 6 skipping (13)] and derivative plasmids ex-
pressing GFP, GFP-hnRNP C1, GFP-TIAR and /or
GFP-TIARQ proteins were co-transfected in HeLa
(Figure 5A and B) and HEK293 (Figure 5C and D)
cells. The patterns of alternatively spliced Fas products
were monitored by RT–PCR and the expression levels of
recombinant GFP fusion proteins by western blotting
(Figure 5A–D). The results showed that overexpression
of hnRNP C1 alone did not affect splicing of Fas exon 6
(Figure 5A–D, compare lanes 1 and 2 with 3). However,
consistent with previous results (13), overexpression of
TIAR promoted a signiﬁcant inclusion of Fas exon 6
Figure 3. The leucine zipper (bZIP)-like motif (bZLM) of hnRNP
C1/C2 interacts with TIAR. (A) Schematic representation of the
domains of human hnRNP C1 protein. The protein sequence of
hnRNP C1 contains an RNA RBD, a bZIP-like motif (bZLM), and
an acidic domain. The RBD and bZLM domains are represented by a
rectangle and an oval, respectively. The white bar represents the proline
(Pro) and Asp/Glu-rich C-terminal domains of hnRNP C1. The black
bars show schematic representation of deletion mutants of human
hnRNP C1. Amino acid numbers are indicated. (B) Interaction
of hnRNP C1 with TIAR involves the bZLM and C-terminal regions
of hnRNP C1 and the Q-rich domain of TIAR. Pull-down assays with
GST, GST-TIAR and GST-TIARQ and in vitro translated full-length
and deleted versions of hnRNP C1 were performed as in Figure 2D.
The positions of full-length and deleted versions of
35S-labeled hnRNP
C1 and molecular weight markers are indicated.
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Co-overexpression of both hnRNP C1 and TIAR
proteins reduced the effect of TIAR on Fas splicing,
resulting in a signiﬁcant skipping of Fas exon 6
(Figure 5A–D, compare lanes 2 and 3 with 4 and 5).
This effect was lost when TIARQ was overexpressed
alone or in combination with hnRNP C1 (Figure 5A–D,
compare lanes 3–5 with 6 and 7). Taken together, these
results are consistent with a repressor activity of hnRNP
C1 on Fas exon 6 splicing mediated by TIAR.
To address whether hnRNP C1 also affects splicing
of other pre-mRNA substrates, FGFR2 splicing was
tested using the RK97 minigene (10; Supplementary
Figure 1SC). GFP-tagged proteins were expressed at
similar levels in HEK293 and HeLa cells (Figure 5A and
C). Overexpression of TIAR caused a signiﬁcant and
reproducible increase in FGFR-2 K-SAM exon inclusion,
whereas overexpression of hnRNP C1 alone had no effect
(Figure 5F, compare lanes 1 with 2 and 4). However,
co-overexpression of TIAR and hnRNP C1 inhibited
K-SAM exon inclusion (Figure 5F, compare lanes 1,
2 and 4 with 5). This effect was lost when TIARQ was
overexpressed alone or in combination with hnRNP C1
(Figure 5F, compare lane 2 with 3 and 6). These results
suggest that hnRNP C1 functions as a trans-acting repres-
sor of TIAR-regulated alternative splicing.
Regulation of Fas splicing by hnRNP C1 is mediated
by HuR
FGFR2 exon K-SAM and Fas exon 6 splicing is com-
pletely dependent on the presence of IAS1 and URI6 se-
quences close to the 50-splice sites and on the recognition
of these sequences by U1 snRNP and TIA-proteins, which
facilitate intron–exon deﬁnition and splicing of the down-
stream introns (10,11,13; Supplementary Figure 1SA and
C). Given that hnRNP C1 binds RNA through U-rich
stretches and both sequences contain cis-acting elements
with these features (Supplementary Figure 2SA), experi-
ments were performed to test whether FGFR2 and
Fas RNAs can be efﬁciently bound by hnRNP C1
(Supplementary Figure 2SA). In vitro assays were carried
Figure 4. Sub-cellular distribution and partial co-localization of hnRNP C1 and TIAR in the nucleus of HeLa cells. (A) Subcellular localization of
hnRNP C1 and TIAR. HeLa cells were transiently transfected with RFP-hnRNP C1 (red) and GFP-TIAR (green) constructs. After 24h
post-transfection, the cells were ﬁxed and the protein distribution was analysed by ﬂuorescence confocal microscopy. (B) Partial co-localization
of hnRNP C1 and TIAR is mediated by the Q-rich domain. HeLa cells were transiently transfected with RFP-hnRNP C1 (red) and GFP-TIARQ
(green) constructs and processed as in (A). From left to right in (A) and (B), images show cells examined using phase contrast (Phase), To-pro-3
staining (To-pro-3), ﬂuorescence from RFP (Cherry-hnRNP C1), ﬂuorescence from GFP (GFP-TIAR and GFP-TIARQ), and merged pictures. In
(A) and (B), lower panels show detailed images. The micrographs were taken with a laser-scanning confocal microscopy using a 63  objective. (C)
Quantiﬁcation of hnRNP C1 and TIAR/TIARQ colocalization in HeLa cells transfected with either RFP-hnRNP C1-GFP-TIAR or RFP-hnRNP
C1-GFP-TIARQ constructs. Represented values are means±SE for two independent experiments with at least seven counted ﬁelds in each of the
experimental conditions analysed.
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and GST-TIAR fusion proteins. RNA binding was
tested by electrophoretic mobility shift assay (EMSA;
Supplementary Figure 2SC and D) and UV-crosslinking
(Supplementary Figure 2SE and F). The results showed
that addition of the same amount of puriﬁed recombinant
TIAR or hnRNP C1 proteins (Supplementary Figure
2SB) results in a signiﬁcant increase in direct binding of
TIAR to both FGFR2 and wt/mutant (the m0 minigene,
with replacement of a uridine-rich sequence on exon 6
[URE6] (13; Supplementary Figure 1SA)) Fas RNAs
(Supplementary Figures 2SC and D and 3S). This prefer-
ential binding of TIAR to both RNAs was also observed
in UV-crosslinking assays (Supplementary Figure 2SE
and F). hnRNP C1 exists as a stable heterotetramer
[(C1)3 (C2)1] that binds RNA cooperatively in the
nucleus (31–33). However, the results of EMSA and
UV-crosslinking assays suggest that hnRNP C1 has a
Figure 5. Functional impact of the TIAR-hnRNP C1 association on alternative pre-mRNA splicing. (A–D) Effect of hnRNP C1 and/or TIAR
overexpression on alternative splicing of mutant U-20C Fas reporter minigene in HeLa (A and B) and HEK293 (C and D) cells. (A and C)
Western-blot analyses (20mg of protein extracts in lanes 1–7) of the expression levels of GFP (lanes 1 and 2), GFP-hnRNP C1 (lane 3),
GFP-TIAR (lane 4), GFP-TIAR plus GFP-hnRNP C1 (lane 5), GFP-TIARQ (lane 6) and GFP-TIARQ plus GFP-hnRNP C1 (lane 7) and
endogenous a-Tubulin (lanes 1-7) in co-transfected HeLa (A) and HEK293 (C) cells. (B and D) Analyses of alternatively spliced products derived
from wt and mutant U-20C Fas minigenes (200ng) co-transfected with pEGFP-C1 (lanes 1 and 2; 500ng), pEGFP-C1-hnRNP C1 (lane 3; 500ng),
pEGFP-C1-TIAR (lane 4; 500ng), pEGFP-C1-TIAR plus hnRNP C1 (lane 5; 500ng of each plasmid), pEGFP-C1-TIARQ (lane 6; 500ng), or
pEGFP-C1-TIARQ plus hnRNP C1 (lane 7; 500ng of each plasmid) plasmids in HeLa (B) and HEK293 (D) cells. In all samples, the total DNA
amount was adjusted with empty pcDNA3.1 plasmid. The values of the ratios between 5-6-7 and 5-7 ampliﬁcation products are means±SE for two
to three independent experiments. (E and F) Effects of overexpression of hnRNP C1 and/or TIAR on alternative splicing of the FGFR2 RK97
reporter minigene in HEK293 cells. (E) Western-blot analysis (20mg of protein extracts in lanes 1–6) of the expression levels of GFP (lane 1),
GFP-TIAR (lane 2), GFP-TIARQ (lane 3), GFP-hnRNP C1 (lane 4), GFP-TIAR plus GFP-hnRNP C1 (lane 5), GFP-TIARQ plus
GFP-hnRNP C1 (lane 6) and endogenous a-tubulin in co-transfected HEK293 cells. (F) Analysis of alternatively spliced products derived from
the RK97 minigene (200ng) co-tranfected with pEGFP-C1 (lanes 1; 500ng), pEGFP-C1-TIAR (lane 2; 500ng), pEGFP-C1-TIARQ (lane 3;
500ng), pEGFP-C1-hnRNP C1 (lane 4; 1000ng), pEGFP-C1-TIAR plus hnRNP C1(lane 5; 500 and 1000ng of each plasmid, respectively), or
pEGFP-C1-TIARQ plus hnRNP C1 (lane 6; 500 and 1000ng of each plasmid, respectively) plasmids in HEK293 cells. In all samples, the total
DNA amount was adjusted with empty pcDNA3.1 plasmid. The values of the ratios between C1-K-SAM-C2-BGH and C1-C2-BGH ampliﬁcation
products are means±SE for two to three independent experiments. Positions of predicted alternatively spliced products are indicated with boxes on
the right.
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these results suggest that FGFR2 and Fas U-rich se-
quences close to both 50-splice sites function as high
afﬁnity sites, mainly facilitating TIAR rather than
hnRNP C1 recruitment. However, the experimental
approach is limited by the use of in vitro RNA-binding
assays, meaning that hnRNP C1 could bind to both
FGFR2 IAS1 and Fas URE6 RNA sequences.
TIA proteins stimulate Fas exon 6 inclusion by
facilitating recognition of its associated 50-splice site by
U1 snRNP, which in turn enhances recognition of the
upstream 30-splice site by U2AF and therefore exon def-
inition. hnRNP I [also known as Polypyrimidine
Tract-Binding (PTB) protein] and Hu antigen R (HuR)
promote exon skipping through an ESS by inhibiting mo-
lecular events that lead to exon deﬁnition via stabilization
of U2AF65 (13,22). A recent report showed extensive as-
sociation between HuR and hnRNP family components,
for example, hnRNP C1/C2 in nuclear hnRNP/mRNP
complexes, consistent with a broader participation in
mRNA processing events (35). To explore this possibility,
MBP pull-downs were used to conﬁrm the interaction
between HuR and hnRNP C1/C2. MBP alone or an
MBP fusion containing full-length HuR were added to
HeLa NEs and their association with hnRNP C1/C2
was analysed by immunoblot for endogenous hnRNP
C1/C2 in the precipitates. hnRNP C1/C2 was pulled
down by MBP-HuR but not by MBP alone (Figure 6A,
compare lanes 1 and 2 with 3 and 4). Co-precipitation of
HuR with hnRNP C1/C2 in NEs was RNA-dependent,
since it was completely lost when extracts were pre-treated
with RNAse A (Figure 6A, compare lanes 3 and 4 with 5
and 6). However, pull-downs using recombinant puriﬁed
MBP-HuR and GST-hnRNP C1 suggested that a protein–
protein interaction is also possible (Figure 6B). To analyse
a potential in vivo interaction between HuR and hnRNP
C1/C2, nuclear co-localization studies were performed
using recombinant GFP-HuR and RFP-hnRNP C1. The
proteins were highly colocalized in the nucleoplasm but
excluded from the nucleolus (Supplementary Figure 4S).
These results support the existence of a genuine associ-
ation between a nuclear pool of HuR and hnRNP C1/
C2 proteins, in agreement with earlier results (35).
To assess whether this association has functional con-
sequences for Fas exon 6 splicing, HeLa cells were
co-transfected with wt Fas minigene and plasmids express-
ing GFP, GFP-hnRNP C1 and /or GFP-HuR. HuR
ovexpression with the wt Fas minigene promoted exon 6
skipping, whereas GFP and hnRNP C1 over-
expression had no effect on Fas exon 6 splicing
(Figure 6C, compare lane 1 with 2 and 3; Supplementary
Figure 5SA). However, HuR and hnRNP C1
co-overexpression promoted a signiﬁcant and reprodu-
cible increase in Fas exon 6 exclusion (Figure 6C, lane 4;
Supplementary Figure 5SA). Nevertheless, the mutant m0
Fas minigene, where URE6 was replaced by a random
sequence (13; Supplementary Figure 1SA), was insensitive
to equivalent levels of GFP, HuR, or hnRNP C
overexpression (Figure 6C, compare lanes 1–4 with 5–8;
Supplementary Figure 5SA). These results suggest that
hnRNP C1 functions as an HuR-dependent corepressor
of Fas exon 6 splicing.
To further conﬁrm that hnRNP C1 displays a repressor
activity mediated by the URE6 RNA silencer, the URE6
sequence was substituted with two MS2 stem-loop-
binding sites in tandem from the bacteriophage MS2
protein (Fas 2xMS2 minigene) (13; Supplementary
Figure 1SB and D). Co-transfection with a plasmid
expressing an MS2-hnRNP C1 fusion protein led to sig-
niﬁcant exon 6 skipping (Figure 6D, lane 4), whereas ex-
pression of MS2 protein alone did not (Figure 6D, lane 1;
Supplementary Figure 5SB). As described previously (22),
expression of MS2-PTB or MS2-HuR fusion proteins also
led to efﬁcient exon 6 skipping (Figure 6D, lanes 2 and 3;
Supplementary Figure 5SB). However, the URE6 substi-
tution rendered the minigene insensitive to GFP-HuR or
GFP-hnRNP C1 overexpression (Figure 6D, compare
lanes 3 and 4 with 5 and 6). The straightforward interpret-
ation of these results is that hnRNP C1 represses exon 6
inclusion in a URE6-dependent manner. Nevertheless,
using an MS2 tethering approach with FGFR2 minigene
A7 (Supplementary Figures 1SD and 6S) in HEK293 cells,
the data obtained in these experiments suggest, perhaps
not surprisingly, a limited contribution of hnRNP C1
alone, because the K-SAM exon is already fully skipped
in HEK293 cells. However, the results also show that
MS2-hnRNP C1 can compete with MS2-TIAR to
modulate K-SAM splicing, illustrating that hnRNP
C1 displays a repressor activity mediated by TIAR
(Supplementary Figure 6S).
To analyse repressor effect of hnRNP C1 per se, the
tethering analysis was extended using modiﬁed Fas
2xMS2 minigenes, which contain a strengthened intron 6
50-splice site, intron 5 30-splice site, or both (22). In this
scenario, hnRNP C1 functioned as a potent repressor of
RNA substrates with weak 50-and 30-splice sites and with a
stronger 50-splice site, but not of those with a stronger
30-splice site (Figure 6E, compare lanes 1–3 and 4–6 with
7–9 and 10–12; Supplementary Figure 5SC). These results
suggest that the repressor capacity of hnRNP C1 on Fas
splicing acts by targeting molecular events that lead to
exon deﬁnition, in agreement with the previous observa-
tions for PTB (13) and HuR (22). The results obtained
using a tethering approach also show that the leucine-rich
domain had sufﬁcient repressor activity to promote Fas
exon 6 skipping (Figure 6F, compare lanes 1, 3 and 5 with
2 and 4; Supplementary Figure 5SD). Thus, the inhibitory
capacity of hnRNP C1 appears to reside in its bZLM
motif.
DISCUSSION
The results of this study show that TIAR/TIAL1, hnRNP
C1/C2 and HuR proteins can play opposite and coopera-
tive roles in the control of Fas alternative splicing. The
splice-enhancing activity of TIAR that facilitates recruit-
ment of U1 snRNP to the weak intron 6 50-splice site is
repressed by the cooperative interaction of HuR and
hnRNP C1/C2 through an ESS by inhibiting molecular
events that lead to exon deﬁnition (Figure 7). These
Nucleic Acids Research, 2010,Vol.38, No. 22 8009observations indicate a functional association of TIA
proteins and HuR with hnRNPs to modulate the molecu-
lar bridging that leads to splicing control.
HnRNP C1/C2 forms the core of the 40S hnRNP
particle in combination with hnRNP A and hnRNP B
proteins. hnRNP C1 and hnRNP C2 form a stable
heterotetramer, (C1)3(C2)1. hnRNP C2 (303 amino
acids) is an alternatively spliced variant of hnRNP C1
(290 amino acids), resulting of the inclusion of 13 amino
acids between glycine 106 and serine 107 (6,31,32).
The results described here indicate that, in HeLa NEs,
hnRNP C1/C2 and TIAR are associated with other
nuclear proteins, such as Matrin 3 and a beta-actin
isoform. Proteomic analyses of immunopuriﬁed human
RNA polymerase II (Pol II) complexes have also
demonstrated that hnRNPs, Matrin 3 and nuclear actin
are associated with the phosphorylated C-terminal
domain of the largest subunit of Pol II (36).
The protein sequence of hnRNP C1/C2 is highly
conserved among vertebrates and contains an RBD and
Figure 6. hnRNP C1 represses Fas exon 6 inclusion through the URE6 exonic silencer. (A and B) Precipitation of endogenous and recombinant
puriﬁed hnRNP C1 by MBP-HuR. (A) MBP pull-down assays were carried out after addition of MBP alone (lanes 1 and 2) or MBP-HuR to NEs
without (lanes 3 and 4) or with (lanes 5 and 6) RNase A treatment, and the resulting pellets (P) and the corresponding supernatants (SN) (10%) were
analysed in parallel by immunobloting with anti-hnRNP C1/C2 antibody. (B) MBP pull-down assays were performed after addition of MBP alone
(lanes 1 and 2) or MBP-HuR (lanes 3 and 4) to recombinant puriﬁed GST-hnRNP-C1 protein and analysed as described in (A). (C) The effects of
HuR (500ng) and hnRNP C1 (1000ng) overexpression on alternative splicing of wt/mutant (m0) Fas minigenes (200ng) in HeLa cells. Analysis of
alternatively spliced products derived from Fas reporter minigenes co-transfected with GFP-tagged plasmids. In all samples, the total DNA amount
was adjusted with empty pcDNA3.1 plasmid. The values of the ratios between 5-6-7 and 5-7 ampliﬁcation products are means±SE for two to three
independent experiments. (D) Tethering of PTB, HuR or hnRNP C1 to Fas exon 6 through heterologous RBDs promotes exon skipping. The Fas
2xMS2 minigene (300ng) containing two MS2 stem-loop-binding sites in tandem adjacent to the URE6 sequence was co-transfected with plasmids
(1000ng) expressing the MS2 fusion proteins indicated. (E) The Fas 2xMS2 minigene was modiﬁed by mutagenesis to strength the intron 6 50-splice
site, intron 5 30-splice site, or both, generating three Fas 2xMS2-derived versions identiﬁed as 50-ss+,3 0-ss+and 50-ss+plus 30-ss+, respectively. The Fas
2xMS2 minigenes (300ng) were co-transfected with plasmids (1000ng) expressing MS2, MS2-HuR, or MS2-hnRNP C1. (F) The Fas 2xMS2
minigene (300ng) was co-transfected with plasmids (1000ng) expressing empty vector MS2, MS2-hnRNP C1 (1–290), MS2-hnRNP C1 (1–118),
MS2-hnRNP C1 (1–240), or MS2-hnRNP C1 (240–290).
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acidic (Asp-Glu-rich) C-terminal domain (Figure 3A)
(31,32). The results of this study suggest that the
protein–protein and RNA–protein associations between
TIAR and hnRNP C1 mainly involve the Q-rich domain
of TIAR and the bZLM and acidic C-terminal domains of
hnRNP C1, whereas the RBD may be irrelevant for these
interactions. Interactions between TIAR and hnRNP C1/
C2 proteins are further documented by the colocalization
of recombinant GFP-TIAR and RFP-hnRNP C1 proteins
in the nucleus of HeLa cells (Figure 4A and C). This
co-localization is lost when the Q-rich domain of TIAR
is deleted (Figure 4B and C). The ability of hnRNP C1 to
repress Fas exon 6 skipping is linked to the bZLM
domain, suggesting that this motif can have a dual role,
promoting both protein–protein and RNA–protein inter-
actions. However, it is still unclear how this domain func-
tions as a repressor of Fas exon 6 splicing. The capacity of
hnRNP C1/C2, TIAR and HuR binding sites to cooperate
in site splice selection may be suggestive of interactions
between C1/C2, HuR and TIA proteins. However,
although this and other studies indicate that at least a
fraction of these proteins exist in similar complexes
(33,36), their ability to establish functional interactions
has never been documented. It is tempting to suggest
that this hnRNP C1/C2 fragment may also counteract
the bridging interaction leading to exon deﬁnition by
reinforcing the repressor activity mediated by HuR
(Figure 7; 22). Here, HuR binding to a high-afﬁnity site
located in the URE6 sequence might enhance the associ-
ation and increase the afﬁnity for nearby sequences. This
would facilitate the association between hnRNP C1/C2
and adjacent silencers, allowing Fas alternative splicing
to be regulated by creating a zone of silencing. HuR and
hnRNP C1/C2 might function like PTB (37) or hnRNP
A1 and hnRNP H (38). However, the role of hnRNP
C1/C2 in alternative splicing control is versatile. For
example, it has been reported that hnRNP C1/C2
down-regulation by small interfering RNAs promotes
exon skipping or the use of more internal 30-splice sites,
suggesting that hnRNP C1/C2 acts as a splicing enhancer
and enforces exon inclusion in a cell-type-dependent
manner (28). In our hands, silencing of hnRNP C1/C2
gene expression mediated by speciﬁc shRNAs against
the 30-untranslated region of the hnRNP C1/C2 mRNA
powerfully inhibits HeLa cell proliferation but has no
effect on alternative splicing patterns of Fas endogenous
and ectopic (minigene) pre-mRNAs (data not shown), a
ﬁnding that is consistent with previous results (27). This
observation is also consistent with Fas exon 6 inclusion
being prevalent in the HeLa cell line (13,22). Interestingly,
these observations agree with the recently described
hnRNP C1/C2 splicing ‘code/map’ (39), showing that
hnRNP C1/C2 recruitment to alternative exons results
in silencing of exon inclusion, whereas binding to the
preceding intron enhances the inclusion of alternative
exons.
Variations in the concentration of general splicing
factors and regulators, including members of the
hnRNP, TIA and Hu protein families, have been
proposed as mechanisms to achieve cell-type or develop-
mental stage-speciﬁc splicing. For example, three
hnRNPs, including hnRNP I (also known as PTB),
hnRNP A1 and hnRNP A2, are up-regulated by c-Myc
and can bind to splicing signals ﬂanking pyruvate kinase
exon 9 and repress its inclusion (40,41). This results in
exon 10 inclusion and generates the embryonic pyruvate
kinase 2 isoform, which promotes aerobic glycolysis in
embryonic and cancer cells. This mechanism is essential
for cell growth, deﬁning a pathway that regulates an al-
ternative splicing event required for tumour cell prolifer-
ation. In another study, we reported that the relative
abundance of TIA1, TIAR, and their isoforms differs in
human tissues and cell lines, with TIAR showing a more
restricted pattern of expression (20). The ﬁnal splicing
outcome will of course also depend on additional factors
that synergize or antagonize TIA1/TIAR activities. For
example, Hu proteins were recently reported to antagonize
TIA1/TIAR to achieve neuron-speciﬁc (42) and Fas (22)
alternative splicing. In addition, post-translational modi-
ﬁcations can modulate the activity of regulatory factors.
TIA1 phosphorylation by the Fas-activated serine/threo-
nine kinase, for instance, increases TIA1 activity and
enhances inclusion of Fas exon 6, thus creating a
positive feedback loop by which Fas signalling induces
higher levels of the proapoptotic form of the receptor
(21). Despite hnRNP C1/C2 being ubiquitously expressed
in mammalian cells, it is also subject to cell-cycle-
dependent regulation (43) and can be phosphorylated
under physiological conditions at Ser-225-228, Ser-240,
Ser-247 and Ser-286 (44,45). Indeed, hnRNP C1/C2 was
identiﬁed as the main substrate phosphorylated by ca-
sein kinases CK1a and CK2 (44,45). Furthermore,
hnRNP C1/C2 undergoes a cycle of phosphorylation-
dephosphorylation in HeLa NEs that modulates its
binding to pre-mRNAs, and this hyperphosphorylation
of hnRNP C1 is mediated by an RNA-dependent kinase
activity in HeLa NEs (30). These observations and the
results shown in Figure 2G might begin to explain the
discrepancies between the TIAR-hnRNP C1 interaction
in RRL versus HeLa NEs. Thus, the requirement for
Figure 7. Model for the regulation of Fas exon 6 splicing by hnRNP
C1/C2, HuR and TIAR. Molecular interactions lead to hnRNP C1/
C2-HuR-dependent exclusion of Fas exon 6. TIAR promotes U1
snRNP recruitment to the 50-splice site of Fas intron 6. This facilitates
exon deﬁnition by enhancing U2AF binding to the 30-splice site of Fas
intron 5, therefore leading to Fas exon 6 inclusion. hnRNP C1/C2
cooperates with HuR to promote Fas exon 6 skipping through the
ESS URE6.
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be modiﬁed in HeLa NEs upon RNase A treatment
(Figure 2F), whereas the coupled transcription and
translation system in RRL could generate sufﬁcient
phosphorylated hnRNP C1 protein. Likewise, endogen-
ous phosphorylation of hnRNP C1/C2 in HeLa NEs
could explain the greater efﬁciency of GST-pull down
experiments with GST-TIAR than GST-hnRNP C1
(Figure 1D and E).
In general, transcriptome diversity is regulated by inter-
actions between cis-acting DNA/RNA elements and
speciﬁc trans-acting proteins and numerous studies
suggest that transcription and post-transcriptional events
(e.g. alternative splicing) are often co-regulated in the
nucleus (46,47). Three very recent reports demonstrated
RNA polymerase II-mediated cross-talk between chroma-
tin structure organization and exon–intron architecture,
implying that exon selection (i.e. ‘splicing code’) might
be modulated by chromatin structure or nucleosome pos-
itioning as well as by histone methylation (48–50). Given
the association of hnRNP C1/C2 with the SWI/SNF chro-
matin remodeling complex (51) and the role of other SWI/
SNF components in alternative splicing (52), hnRNP C1/
C2 may mediate some effects in a co-transcriptionally de-
pendent manner. We now know that a key link between
transcription and RNA splicing is provided by different
families of highly conserved RNA-binding proteins
known as hnRNPs or SR proteins (36). Given abundant
evidence for co-transcriptional pre-mRNA splicing of
most eukaryotic genes, it is widely accepted that
hnRNPs participate in spliceosome assembly on nascent
RNAs to catalyse intron removal before the completion of
transcription, thus explaining the association of hnRNPs
with active genes. An overall hypothesis has emerged that
pre-mRNA-containing ribonucleoprotein complexes
(pre-mRNPs) are the functional equivalent of ‘post-
transcriptional operons’. Pre-mRNA splicing begins
co-transcriptionally on chromatin and this feature inﬂu-
ences the alternative splicing outcome; for example,
changes in transcription elongation rates and pausing
have an effect on exon inclusion (46,47). This suggests
that the kinetics of splice-site synthesis and the time for
interaction with splicing factors before synthesis of the
next splice site have a role in the combinatorial and
coordinated control of alternative splicing (53,54). These
ﬁndings support a model in which hnRNP C1/C2, TIAR,
HuR and U1 snRNP are co-transcriptionally recruited
to nascent RNA Pol II transcripts to promote spliceo-
some assembly. The combination of these factors and
the co-transcriptional recruitment would be expected
to increase the ﬁdelity of the earliest recognition of
weak 50splice sites in exons of nascent pre-mRNAs.
Modiﬁcations in the amounts or activities of TIA1/
TIAR, PTB, SPF45, RBM5, HuR and /or hnRNP C1/
C2 (11,13,22,55,56) and their capacity to interact and
modulate the splicing decision can regulate Fas exon 6
splicing to produce isoforms that activate or inhibit the
extrinsic apoptosis pathway. Control of Fas splicing may
be strongly dependent on the coordinated and combina-
torial arrangement of several binding sites that coexist in
very close proximity. This capacity to collaborate is not
surprising, since these proteins display redundant binding
speciﬁcity and have similar structures. The results of
this study also raise the possibility that these proteins
improve interactions with other hnRNPs, suggesting that
associations via other RNA-binding proteins represent an
efﬁcient system to build speciﬁcity with non-speciﬁc
RNA-binding proteins (57) and expand the range of
‘splicing code’ options (39,58). Many factors can both
activate and repress splicing in different contexts, and
they may have synergistic or antagonistic effects on the
co-transcriptional decision involved in alternative splicing.
More work will be required to ascertain the mechanism(s)
through which hnRNP C1/C2 and other hnRNPs proteins
inﬂuence splice site selection.
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